Detailed Information on Publication Record
2022
Promising effect of topical antimicrobial ‘biobetters’ against methicillin-resistant Staphylococcus aureus strains
RAŠKA, Filip, Břetislav LIPOVÝ, Jakub HOLOUBEK, Š. KOBZOVÁ, Lukáš VACEK et. al.Basic information
Original name
Promising effect of topical antimicrobial ‘biobetters’ against methicillin-resistant Staphylococcus aureus strains
Authors
RAŠKA, Filip (203 Czech Republic, belonging to the institution), Břetislav LIPOVÝ (203 Czech Republic, belonging to the institution), Jakub HOLOUBEK (203 Czech Republic, belonging to the institution), Š. KOBZOVÁ (203 Czech Republic), Lukáš VACEK (203 Czech Republic, belonging to the institution), L. VOJTOVÁ and L. JANDA (203 Czech Republic)
Edition
Burns, OXON, ELSEVIER SCI LTD, 2022, 0305-4179
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30212 Surgery
Country of publisher
United Kingdom of Great Britain and Northern Ireland
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 2.700
RIV identification code
RIV/00216224:14110/22:00127028
Organization unit
Faculty of Medicine
UT WoS
000880116100012
Keywords in English
topical antimicrobial 'biobetters'; methicillin-resistant Staphylococcus aureus strains
Tags
International impact, Reviewed
Změněno: 16/1/2023 13:36, Mgr. Tereza Miškechová
Abstract
V originále
Successful control of burn wound infection is one of the keystones in the successful treatment of patients with burn injury. The increase in the prevalence of resistant strains of pathogens dramatically reduces the options of antibiotic treatment. Infectious complications caused by methicillin-resistant Staphylococcus aureus (MRSA) are known to be associated with significantly higher mortality than those caused by methicillin-sensitive strains (MSSA; 42 % and 18 %, respectively). This situation underlines the necessity for other strategies to control infectious complications of burn wounds. The use of enzybiotics (such as endolysins and lysostaphins), specific products of bacteriophages or competing bacteria, appears to be a promising alternative approach. Their advantages include high specificity and, in particular, they appear less susceptible to the development of resistant strains of bacteria. The principal limitations of the current options for the use of enzybiotics in the topical treatment of MRSA-induced burn wound infections are 1) low production associated with a high price, 2) short duration of the enzymatic activity, which is caused by the structural instability of enzymes resulting in protein denaturation and 3) low resistance of the enzyme to proteases – in particular, matrix metalloproteinases (MMPs), which are produced in the burn wound area in high amounts.